61 results
DEFM14A
CFMS
Conformis Inc
24 Jul 23
Proxy related to merger
8:00am
relating to our strategy, goals, future focus areas and the value of the proposed transaction to our stockholders. These forward-looking statements … personalized knee implant. The Company’s strategy during this period was to increase adoption of Imprint, while also offering patients greater choice through
PREM14A
CFMS
Conformis Inc
14 Jul 23
Preliminary proxy related to merger
4:28pm
statements relating to our strategy, goals, future focus areas and the value of the proposed transaction to our stockholders. These forward-looking statements … ”) as a deluxe service upgrade in order for patients to obtain a fully personalized knee implant. The Company’s strategy during this period
DEFA14A
CFMS
Conformis Inc
26 Jun 23
Additional proxy soliciting materials
5:25pm
reasonably apprised on a prompt basis of proposed strategy and other significant decisions with respect to any such stockholder litigation, and provide
8-K
EX-2.1
CFMS
Conformis Inc
23 Jun 23
Conformis Announces Definitive Agreement to be Acquired by restor3d for a Purchase Price of $2.27 Per Share in Cash
7:45am
such stockholder litigation, (b) keep Parent reasonably apprised on a prompt basis of proposed strategy and other significant decisions with respect to any
8-K
EX-99.1
62bj2wj jj
2 Nov 22
Conformis Reports Third Quarter 2022 Financial Results
4:12pm
8-K
EX-99.1
i5ma3
8 Aug 22
Conformis Reports Second Quarter 2022 Financial Results
4:47pm
8-K
EX-99.1
l8d8dnx
14 Mar 22
Conformis, Inc. Appoints Denise Pedulla as Chief Legal Officer and Corporate Secretary
5:19pm
8-K
EX-99.1
980npweaxvy4ts6h 8w
3 Nov 21
Conformis Reports Third Quarter 2021 Financial Results
4:12pm
8-K
EX-99.1
43yt3g 2a7vh
20 Sep 21
Conformis, Inc. Provides Business Update
4:31pm
8-K
EX-99.1
xnzpze0xxbieg
4 Aug 21
Conformis Reports Second Quarter 2021 Financial Results
4:16pm